Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorANDRADE, Luciana Nogueira de Sousa
dc.contributor.authorOTAKE, Andreia Hanada
dc.contributor.authorCARDIM, Silvia Guedes Braga
dc.contributor.authorSILVA, Felipe I. Lelis da
dc.contributor.authorSAKAMOTO, Mariana Mari Ikoma
dc.contributor.authorFURUYA, Tatiane Katsue
dc.contributor.authorUNO, Miyuki
dc.contributor.authorPASINI, Fatima Solange
dc.contributor.authorCHAMMAS, Roger
dc.identifier.citationSCIENTIFIC REPORTS, v.9, article ID 14482, 12p, 2019
dc.description.abstractExtracellular vesicles (EVs) are emerging as key players in intercellular communication. EVs can transfer biological macromolecules to recipient cells, modulating various physiological and pathological processes. It has been shown that tumor cells secrete large amounts of EVs that can be taken up by malignant and stromal cells, dictating tumor progression. In this study, we investigated whether EVs secreted by melanoma cells in response to chemotherapy modulate tumor response to alkylating drugs. Our findings showed that human and murine melanoma cells secrete more EVs after treatment with temozolomide and cisplatin. We observed that EVs shed by melanoma cells after temozolomide treatment modify macrophage phenotype by skewing macrophage activation towards the M2 phenotype through upregulation of M2-marker genes. Moreover, these EVs were able to favor melanoma re-growth in vivo, which was accompanied by an increase in Arginase 1 and IL10 gene expression levels by stromal cells and an increase in genes related to DNA repair, cell survival and stemness in tumor cells. Taken together, this study suggests that EVs shed by tumor cells in response to chemotherapy promote tumor repopulation and treatment failure through cellular reprogramming in melanoma cells.eng
dc.description.sponsorshipCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)CAPES [001]
dc.description.sponsorshipFapesp (Fundacao de Apoio a Pesquisa do Estado de Sao Paulo)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/03742-0, 2018/01366-2]
dc.description.sponsorshipCNPq (Conselho Nacional de Desenvolvimento Cientifico e tecnologico)National Council for Scientific and Technological Development (CNPq)
dc.relation.ispartofScientific Reports
dc.subject.otherbreast-cancer cellseng
dc.titleExtracellular Vesicles Shedding Promotes Melanoma Growth in Response to Chemotherapyeng
dc.rights.holderCopyright NATURE PUBLISHING GROUPeng
dc.subject.wosMultidisciplinary Scienceseng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng, Felipe I. Lelis da:Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, Inst Canc Estado Sao Paulo,Ctr Invest Translac On, Ave Dr Arnaldo 251, BR-01246000 Sao Paulo, SP, Brazil
hcfmusp.relation.referenceAbels ER, 2016, CELL MOL NEUROBIOL, V36, P301, DOI 10.1007/s10571-016-0366-zeng
hcfmusp.relation.referenceAl-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725eng
hcfmusp.relation.referenceAyob AZ, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0426-4eng
hcfmusp.relation.referenceBaj-Krzyworzeka M, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0789-9eng
hcfmusp.relation.referenceBardi GT, 2018, CYTOKINE, V105, P63, DOI 10.1016/j.cyto.2018.02.002eng
hcfmusp.relation.referenceBecker A, 2016, CANCER CELL, V30, P836, DOI 10.1016/j.ccell.2016.10.009eng
hcfmusp.relation.referenceBegicevic RR, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112362eng
hcfmusp.relation.referenceChang JM, 2019, FASEB J, V33, P114, DOI 10.1096/fj.201800019RReng
hcfmusp.relation.referenceChow A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05750eng
hcfmusp.relation.referenceCorcoran C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050999eng
hcfmusp.relation.referenceCosta-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169eng
hcfmusp.relation.referencede Vrij J, 2015, INT J CANCER, V137, P1630, DOI 10.1002/ijc.29521eng
hcfmusp.relation.referenceDesrochers LM, 2016, DEV CELL, V37, P301, DOI 10.1016/j.devcel.2016.04.019eng
hcfmusp.relation.referenceEl-Khattouti A, 2014, CANCER LETT, V343, P123, DOI 10.1016/j.canlet.2013.09.024eng
hcfmusp.relation.referenceEton O, 2002, J CLIN ONCOL, V20, P2045, DOI 10.1200/JCO.2002.07.044eng
hcfmusp.relation.referenceFeng QY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14450eng
hcfmusp.relation.referenceHong BS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-556eng
hcfmusp.relation.referenceHuang Z, 2017, ONCOL RES, V25, P651, DOI 10.3727/096504016X14752792816791eng
hcfmusp.relation.referenceJi ZY, 2015, J INVEST DERMATOL, V135, P1863, DOI 10.1038/jid.2015.105eng
hcfmusp.relation.referenceJung T, 2009, NEOPLASIA, V11, P1093, DOI 10.1593/neo.09822eng
hcfmusp.relation.referenceKe XQ, 2017, NEOPLASIA, V19, P941, DOI 10.1016/j.neo.2017.06.007eng
hcfmusp.relation.referenceKeklikoglou I, 2019, NAT CELL BIOL, V21, P190, DOI 10.1038/s41556-018-0256-3eng
hcfmusp.relation.referenceKhayat D, 2002, J CLIN ONCOL, V20, P2411, DOI 10.1200/JCO.2002.20.10.2411eng
hcfmusp.relation.referenceKing HW, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-421eng
hcfmusp.relation.referenceKreger BT, 2016, CANCERS, V8, DOI 10.3390/cancers8120111eng
hcfmusp.relation.referenceLi YQ, 2012, CANCER RES, V72, P576, DOI 10.1158/0008-5472.CAN-11-3070eng
hcfmusp.relation.referenceLivak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262eng
hcfmusp.relation.referenceLogozzi M, 2017, CANCER LETT, V403, P318, DOI 10.1016/j.canlet.2017.06.036eng
hcfmusp.relation.referenceLundholm M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108925eng
hcfmusp.relation.referenceLv LH, 2012, J BIOL CHEM, V287, P15874, DOI 10.1074/jbc.M112.340588eng
hcfmusp.relation.referenceLv MM, 2014, TUMOR BIOL, V35, P10773, DOI 10.1007/s13277-014-2377-zeng
hcfmusp.relation.referenceMatsumoto A, 2017, CANCER SCI, V108, P1803, DOI 10.1111/cas.13310eng
hcfmusp.relation.referenceMattia G, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0059-7eng
hcfmusp.relation.referenceNazarenko I, 2010, CANCER RES, V70, P1668, DOI 10.1158/0008-5472.CAN-09-2470eng
hcfmusp.relation.referenceNoy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010eng
hcfmusp.relation.referenceParolini I, 2009, J BIOL CHEM, V284, P34211, DOI 10.1074/jbc.M109.041152eng
hcfmusp.relation.referencePeinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753eng
hcfmusp.relation.referencePhadke MS, 2015, MOL CANCER THER, V14, P1354, DOI 10.1158/1535-7163.MCT-14-0832eng
hcfmusp.relation.referencePiao Yin Ji, 2018, Oncotarget, V9, P7398, DOI 10.18632/oncotarget.23238eng
hcfmusp.relation.referenceQu L, 2016, CANCER CELL, V29, P653, DOI 10.1016/j.ccell.2016.03.004eng
hcfmusp.relation.referenceSamuel P., 2018, PHILOS T R SOC LON B, V373, P1737eng
hcfmusp.relation.referenceShimoda M, 2017, BBA-MOL CELL RES, V1864, P1989, DOI 10.1016/j.bbamcr.2017.05.027eng
hcfmusp.relation.referenceShinohara H, 2017, J IMMUNOL, V199, P1505, DOI 10.4049/jimmunol.1700167eng
hcfmusp.relation.referenceTian H, 2015, CANCER LETT, V358, P8, DOI 10.1016/j.canlet.2014.12.038eng
hcfmusp.relation.referencevan Schaijik B, 2018, J CLIN PATHOL, V71, P88, DOI 10.1136/jclinpath-2017-204815eng
hcfmusp.relation.referenceVella LJ, 2017, NEOPLASIA, V19, P932, DOI 10.1016/j.neo.2017.07.002eng
hcfmusp.relation.referenceWendler F, 2017, ONCOGENE, V36, P877, DOI 10.1038/onc.2016.253eng
hcfmusp.relation.referenceWouters J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076550eng
hcfmusp.relation.referenceWu LJ, 2016, TUMOR BIOL, V37, P12169, DOI 10.1007/s13277-016-5071-5eng
hcfmusp.relation.referenceWysoczynski M, 2009, INT J CANCER, V125, P1595, DOI 10.1002/ijc.24479eng
hcfmusp.relation.referenceXiao X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089534eng
hcfmusp.relation.referenceYanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066eng
hcfmusp.relation.referenceYe SB, 2016, J PATHOL, V240, P329, DOI 10.1002/path.4781eng
hcfmusp.relation.referenceYe SB, 2014, ONCOTARGET, V5, P5439, DOI 10.18632/oncotarget.2118eng
hcfmusp.relation.referenceZeng AL, 2017, ONCOGENE, V36, P5369, DOI 10.1038/onc.2017.134eng
hcfmusp.relation.referenceZhang HY, 2016, CANCER LETT, V375, P331, DOI 10.1016/j.canlet.2016.03.026eng
hcfmusp.relation.referenceZhang HC, 2012, STEM CELLS DEV, V21, P3289, DOI 10.1089/scd.2012.0095eng
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MDR
Departamento de Radiologia - FM/MDR

Artigos e Materiais de Revistas Científicas - HC/ICESP
Instituto do Câncer do Estado de São Paulo - HC/ICESP

Artigos e Materiais de Revistas Científicas - LIM/05
LIM/05 - Laboratório de Poluição Atmosférica Experimental

Artigos e Materiais de Revistas Científicas - LIM/24
LIM/24 - Laboratório de Oncologia Experimental

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar

Files in This Item:
File Description SizeFormat 
art_ANDRADE_Extracellular_Vesicles_Shedding_Promotes_Melanoma_Growth_in_Response_2019.PDFpublishedVersion (English)6.26 MBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.